TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

Cell Therapeutics, Inc. Long Term Shareholder Investigation

  • If you are a current long term investor in Cell Therapeutics, Inc. (NASDAQ: CTIC) stock, including those CTIC investors who purchased their CTIC stock prior to May 2009 and continue to hold their CTIC shares, you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please use this form. You may also send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Investigation Overview

A Cell Therapeutics investor filed a lawsuit on behalf of purchasers of the common stock of Cell Therapeutics, Inc. (CTIC) between May 5, 2009 and February 8, 2010, including those who purchased shares in the Secondary Offering on or around July 22, 2009. Meanwhile an investigation on behalf of current long term investors Cell Therapeutics, Inc. (NASDAQ: CTIC), including those CTIC in...



You must register (for free) or login to view the entire investigation.

Click here to Sign In or Register (for a free account)

@screen width:
@theme:
@breakpoints:
@layout: